CLINICAL_TRIALS
trial_result
· 2013-07-29
Clinical Trial Update: Phase 2 Study of Tapentadol Prolonged Release in Cancer Pain Participants [Phase 2]
Summary
This document reports results from a Phase 2 trial evaluating tapentadol prolonged-release for cancer-related pain.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Janssen Pharmaceutical K.K. | Conditions: Pain, Cancer | Phase 2 | Status: COMPLETED | Results posted: 2013-07-29